Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma

NCT01227434 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01227434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2010
Completion date
December 31, 2013
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, glioblastoma, gliosarcoma